SAGENT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

WILMINGTON, Del.--()--Rigrodsky & Long, P.A.:

  • Do you own shares of Sagent Pharmaceuticals, Inc. (NASDAQ GS: SGNT)?
  • Did you purchase any of your shares prior to July 11, 2016?
  • Do you think the proposed buyout price is too low?
  • Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Sagent Pharmaceuticals, Inc. (“Sagent” or the “Company”) (NASDAQ GS: SGNT) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Nichi-Iko Pharmaceutical Co., Ltd (“Nichi-Iko”), in a transaction valued at approximately $736 million.

Click here to learn more: http://rigrodskylong.com/investigations/sagent-pharmaceuticals-inc-sgnt.

Under the terms of the agreement, shareholders of Sagent will receive $21.75 in cash for each share of Sagent common stock.

The investigation concerns whether Sagent’s board of directors failed to adequately shop the Company and obtain the best possible value for Sagent shareholders before entering into an agreement with Nichi-Iko. According to Yahoo! Finance, at least one analyst has issued a price target for Sagent stock at $25.00 per share.

If you own the common stock of Sagent and purchased your shares before July 11, 2016, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at: http://rigrodskylong.com/investigations/sagent-pharmaceuticals-inc-sgnt.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contacts

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
888-969-4242
302-295-5310
Fax: 302-654-7530
info@rl-legal.com
http://www.rigrodskylong.com

Release Summary

SAGENT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Contacts

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
888-969-4242
302-295-5310
Fax: 302-654-7530
info@rl-legal.com
http://www.rigrodskylong.com